Medicare Enrolled
Dr. Ketan Doshi, M.D.
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Doshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doshi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Doshi
Dr. Ketan Doshi is a hematology & oncology in Ocala, FL, with 18 years in practice. Based on federal Medicare data, Dr. Doshi performed 133,084 Medicare services across 6,054 unique beneficiaries.
Between the years covered by Open Payments, Dr. Doshi received a total of $120,972 from 107 pharmaceutical and/or device companies across 1336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Doshi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 4% volume in FL$ $120,972 industry payments
Medicare Practice Summary
Medicare Utilization ↗133,084
Medicare services
Top 4% in FL for hematology & oncology
6,054
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,394 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 38,640 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 18,800 | $43 | $146 |
| Darbepoetin injection (Aranesp) for anemia | 17,750 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 9,720 | $18 | $70 |
| Iron infusion (Monoferric) | 8,200 | $17 | $74 |
| Anti-nausea injection (fosaprepitant) | 6,000 | $0 | $6 |
| Paclitaxel chemotherapy injection | 4,505 | $0 | $1 |
| Immune globulin infusion (Octagam) | 3,898 | $34 | $251 |
| Anti-nausea injection (aprepitant) | 3,120 | $1 | $9 |
| Complete blood count (CBC) with differential | 2,449 | $8 | $35 |
| Blood draw (venipuncture) | 2,305 | $8 | $19 |
| Comprehensive metabolic blood panel | 1,631 | $10 | $62 |
| Contrast dye for imaging (iodine-based) | 1,600 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,444 | $0 | $1 |
| Lactate dehydrogenase (enzyme) level | 1,373 | $6 | $30 |
| Injection, granisetron hydrochloride, 100 mcg | 1,260 | $0 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 880 | $1 | $122 |
| Epoetin alfa injection (Retacrit) for anemia | 870 | $6 | $30 |
| Ferritin level test (iron stores) | 619 | $13 | $58 |
| Iron level test | 608 | $6 | $26 |
| Iron binding capacity test | 608 | $9 | $34 |
| Office visit, established patient (20-29 min) | 601 | $62 | $148 |
| Injection of additional new drug or substance into vein | 562 | $12 | $105 |
| Drug injection, under skin or into muscle | 475 | $10 | $93 |
| Vitamin B-12 level test | 395 | $15 | $74 |
| Folic acid level test | 394 | $14 | $71 |
| Administration of chemotherapy into vein, 1 hour or less | 364 | $97 | $686 |
| Magnesium level test | 327 | $7 | $28 |
| Injection, carboplatin, 50 mg | 248 | $2 | $300 |
| Office visit, established patient (30-39 min) | 233 | $95 | $224 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 212 | $47 | $304 |
| Measurement of substance using immunoassay technique | 172 | $17 | $181 |
| Nephelometry, test method using light | 172 | $13 | $176 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 169 | $20 | $124 |
| Hospital follow-up visit, moderate complexity | 154 | $64 | $157 |
| Injection, diphenhydramine hcl, up to 50 mg | 138 | $1 | $7 |
| Injection, magnesium sulfate, per 500 mg | 110 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 104 | $16 | $97 |
| Antibody identification test, platelet associated immunoglobulin assay | 102 | $12 | $155 |
| Administration of additional new drug or substance into vein, 1 hour or less | 102 | $49 | $334 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 100 | $25 | $141 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 92 | $1 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 90 | $25 | $249 |
| Office visit, established patient, complex (40-54 min) | 87 | $136 | $301 |
| Measurement of immunoglobulin light chains | 86 | $17 | $60 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 84 | $1 | $19 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 83 | $16 | $70 |
| Administration of chemotherapy into vein, each additional hour | 72 | $22 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 67 | $21 | $152 |
| Thyroid stimulating hormone (TSH) test | 62 | $16 | $78 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 61 | $67 | $214 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 60 | $56 | $205 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 60 | $408 | $638 |
| Infusion, normal saline solution , 1000 cc | 60 | $2 | $19 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 56 | $1,203 | $4,120 |
| Unclassified drugs | 53 | $1 | $9 |
| Initial hospital admission, moderate complexity | 50 | $104 | $297 |
| Free thyroxine (T4) test | 48 | $9 | $63 |
| Administration of additional new drug or substance into vein using push technique | 47 | $42 | $281 |
| Infusion into a vein for hydration, each additional hour | 44 | $10 | $73 |
| Adrenocorticotropic hormone (acth) level | 39 | $38 | $166 |
| PSA test (prostate cancer screening) | 39 | $18 | $91 |
| New patient office visit (45-59 min) | 36 | $120 | $343 |
| Irrigation of implanted venous access drug delivery device | 35 | $17 | $111 |
| New patient office visit, complex (60-74 min) | 32 | $176 | $432 |
| Collection of blood sample from implanted device | 31 | $20 | $64 |
| Carcinoembryonic antigen (cea) protein level | 28 | $19 | $96 |
| Drawing of blood for a medical problem | 26 | $67 | $251 |
| Hospital follow-up visit, high complexity | 25 | $96 | $232 |
| Office visit, established patient (10-19 min) | 23 | $37 | $88 |
| Automated urinalysis | 19 | $2 | $16 |
| Injection of drug or substance into vein | 18 | $29 | $240 |
| Ct scan of chest with contrast | 15 | $89 | $1,005 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 15 | $13 | $91 |
| CT scan of abdomen and pelvis with contrast | 14 | $214 | $1,400 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 13 | $136 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.6% high complexity
80.3% medium
10.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$120,972
Total received (2018-2024)
Avg $17,282/year across 7 years
Top 8% in FL for hematology & oncology
107
Companies
1,336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$86,474 (71.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,297 (18.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,202 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$15,123
2023$11,304
2022$23,637
2021$13,460
2020$15,954
2019$22,330
2018$19,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$14,328
Bayer HealthCare Pharmaceuticals Inc.
$10,785
GlaxoSmithKline, LLC.
$6,262
Novartis Pharmaceuticals Corporation
$5,965
Ipsen Biopharmaceuticals, Inc
$5,801
Celgene Corporation
$5,152
TESARO, Inc.
$4,849
BeiGene USA, Inc.
$4,418
Eisai Inc.
$4,286
Genentech USA, Inc.
$4,149
Agios Pharmaceuticals, Inc.
$3,995
Exelixis Inc.
$3,495
Gilead Sciences, Inc.
$3,233
Pharmacosmos Therapeutics Inc.
$2,896
Novocure Inc.
$2,657
AMAG Pharmaceuticals, Inc.
$2,640
Astellas Pharma US Inc
$2,553
E.R. Squibb & Sons, L.L.C.
$2,535
CTI BioPharma Corp.
$2,465
ARGENX US, INC.
$2,200
Incyte Corporation
$2,121
PFIZER INC.
$1,994
NOVARTIS PHARMACEUTICALS CORPORATION
$1,575
Heron Therapeutics, Inc.
$1,517
Taiho Oncology, Inc.
$1,470
Epizyme, Inc.
$1,391
EISAI INC.
$1,215
Janssen Biotech, Inc.
$1,169
Daiichi Sankyo Inc.
$919
Coherus Biosciences Inc.
$918
Amgen Inc.
$862
Lilly USA, LLC
$799
EMD Serono, Inc.
$660
Acceleron Pharma, Inc.
$650
Puma Biotechnology, Inc.
$648
Seagen Inc.
$630
Merck Sharp & Dohme LLC
$601
Merck Sharp & Dohme Corporation
$585
Takeda Pharmaceuticals U.S.A., Inc.
$486
Seattle Genetics, Inc.
$350
GENZYME CORPORATION
$323
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
Pharmacyclics LLC, An AbbVie Company
$282
JAZZ PHARMACEUTICALS INC.
$277
Janssen Pharmaceuticals, Inc
$249
Clovis Oncology, Inc.
$220
Octapharma USA, Inc.
$209
ARRAY BIOPHARMA INC
$204
Kite Pharma, Inc.
$200
Pharmacyclics LLC, an AbbVie Company
$176
Regeneron Healthcare Solutions, Inc.
$172
Genmab U.S., Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$153
Rigel Pharmaceuticals, Inc.
$152
Mirati Therapeutics, Inc.
$147
Stemline Therapeutics Inc.
$134
Kyowa Kirin, Inc.
$127
Stryker Corporation
$125
Janssen Scientific Affairs, LLC
$116
MorphoSys, US Inc.
$101
Alexion Pharmaceuticals, Inc.
$91
TerSera Therapeutics LLC
$90
ADC Therapeutics America, Inc.
$89
Lexicon Pharmaceuticals, Inc.
$80
Amneal Pharmaceuticals LLC
$74
Apellis Pharmaceuticals, Inc.
$74
Jazz Pharmaceuticals Inc.
$73
AVEO Pharmaceuticals, Inc.
$68
Epizyme, Inc.,
$67
TG THERAPEUTICS, INC.
$65
CSL Behring
$63
ABBVIE INC.
$59
G1 Therapeutics, Inc.
$59
Foundation Medicine, Inc.
$56
SOBI, INC
$51
Astellas Pharma Global Development
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$47
AcelRx Pharmaceuticals, Inc.
$45
Aveo Pharmaceuticals, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$42
Servier Pharmaceuticals LLC
$42
Dova Pharmaceuticals
$38
Karyopharm Therapeutics Inc.
$38
Immunocore Limited
$36
TG Therapeutics, Inc.
$32
Horizon Therapeutics plc
$32
AbbVie, Inc.
$32
PharmaEssentia USA Corporation
$32
Secura Bio, Inc.
$30
ImmunoGen, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$27
Emmaus Medical, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
Tempus AI, Inc
$23
Sobi, Inc
$21
PUMA BIOTECHNOLOGY, INC.
$21
Menarini Silicon Biosystems, Inc.
$20
Medtronic, Inc.
$20
Array BioPharma Inc.
$18
GE HealthCare
$18
Sun Pharmaceutical Industries Inc.
$16
Blueprint Medicines Corporation
$14
SECURA BIO, INC.
$13
Dendreon Pharmaceuticals LLC
$12
AbbVie Inc.
$12
SANOFI-AVENTIS U.S. LLC
$11
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 25.9% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BB-2121 · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cellsearch · Cinvanti · Creon · DARZALEX · DOPTELET · DSUVIA · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MAKO · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · Oncology · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · Quzyttir · REBLOZYL · RETEVMO · REYATAZ · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tepmetko · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYVGART · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in FL.
Equivalent to $91 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
6
Per 100K population
1.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Doshi is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and high industry engagement (consulting-driven, top 8%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Doshi experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Doshi performed 38,640 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doshi receive payments from pharmaceutical companies?
Yes. Dr. Doshi received a total of $120,972 from 107 companies across 1,336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doshi's costs compare to other hematology & oncologys in Ocala?
Dr. Doshi's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Ocala
Browse hematology & oncologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology